Cargando…
Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disease of the gastrointestinal tract, associated with high levels of inflammatory cytokine production. Human caspases-4 and -5, and their murine ortholog caspase-11, are essential components of the innate immune pathway, capable o...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194562/ https://www.ncbi.nlm.nih.gov/pubmed/35712726 http://dx.doi.org/10.3389/fphar.2022.919567 |
_version_ | 1784726757286346752 |
---|---|
author | Smith, Aoife P. Creagh, Emma M. |
author_facet | Smith, Aoife P. Creagh, Emma M. |
author_sort | Smith, Aoife P. |
collection | PubMed |
description | Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disease of the gastrointestinal tract, associated with high levels of inflammatory cytokine production. Human caspases-4 and -5, and their murine ortholog caspase-11, are essential components of the innate immune pathway, capable of sensing and responding to intracellular lipopolysaccharide (LPS), a component of Gram-negative bacteria. Following their activation by LPS, these caspases initiate potent inflammation by causing pyroptosis, a lytic form of cell death. While this pathway is essential for host defence against bacterial infection, it is also negatively associated with inflammatory pathologies. Caspases-4/-5/-11 display increased intestinal expression during IBD and have been implicated in chronic IBD inflammation. This review discusses the current literature in this area, identifying links between inflammatory caspase activity and IBD in both human and murine models. Differences in the expression and functions of caspases-4, -5 and -11 are discussed, in addition to mechanisms of their activation, function and regulation, and how these mechanisms may contribute to the pathogenesis of IBD. |
format | Online Article Text |
id | pubmed-9194562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91945622022-06-15 Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease Smith, Aoife P. Creagh, Emma M. Front Pharmacol Pharmacology Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disease of the gastrointestinal tract, associated with high levels of inflammatory cytokine production. Human caspases-4 and -5, and their murine ortholog caspase-11, are essential components of the innate immune pathway, capable of sensing and responding to intracellular lipopolysaccharide (LPS), a component of Gram-negative bacteria. Following their activation by LPS, these caspases initiate potent inflammation by causing pyroptosis, a lytic form of cell death. While this pathway is essential for host defence against bacterial infection, it is also negatively associated with inflammatory pathologies. Caspases-4/-5/-11 display increased intestinal expression during IBD and have been implicated in chronic IBD inflammation. This review discusses the current literature in this area, identifying links between inflammatory caspase activity and IBD in both human and murine models. Differences in the expression and functions of caspases-4, -5 and -11 are discussed, in addition to mechanisms of their activation, function and regulation, and how these mechanisms may contribute to the pathogenesis of IBD. Frontiers Media S.A. 2022-05-31 /pmc/articles/PMC9194562/ /pubmed/35712726 http://dx.doi.org/10.3389/fphar.2022.919567 Text en Copyright © 2022 Smith and Creagh. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Smith, Aoife P. Creagh, Emma M. Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease |
title | Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease |
title_full | Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease |
title_fullStr | Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease |
title_full_unstemmed | Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease |
title_short | Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease |
title_sort | caspase-4 and -5 biology in the pathogenesis of inflammatory bowel disease |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194562/ https://www.ncbi.nlm.nih.gov/pubmed/35712726 http://dx.doi.org/10.3389/fphar.2022.919567 |
work_keys_str_mv | AT smithaoifep caspase4and5biologyinthepathogenesisofinflammatoryboweldisease AT creaghemmam caspase4and5biologyinthepathogenesisofinflammatoryboweldisease |